Clinical Trial Update: Trial of Angiotensin Converting Enzyme Inhibition in Infants With Single Ventricle--Pediatric Heart Network [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ACE inhibitor therapy in infants with single-ventricle congenital heart disease has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Heart Failure

Drugs mentioned

• ACE inhibitor (unspecified)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Heart Defects, Congenital, Heart Failure, Congestive | Phase 3 | Status: COMPLETED | Results posted: 2010-09-16